MASS
908 Devices Inc. NASDAQ Listed Dec 18, 2020$8.61
-2.71%
vs $8.85
Mkt Cap $325.6M
52w Low $5.03
83.1% of range
52w High $9.34
50d MA $7.62
200d MA $6.89
P/E (TTM)
—
EV/EBITDA
—
P/B
2.2x
Debt/Equity
0.1x
ROE
13.6%
P/FCF
-14.0x
RSI (14)
57.50
ATR (14)
$0.46
Beta
0.53
50d MA
$7.62
200d MA
$6.89
Avg Volume
285.0K
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
645 Summer Street · Boston, MA 02210 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | BMO | -0.15 | -0.22 | -46.7% | 7.09 | +7.1% | +13.7% | +0.2% | +1.1% | -2.9% | -3.5% | — |
| Mar 3, 2026 | BMO | -0.06 | -0.05 | +16.7% | 6.32 | +0.0% | +6.6% | +0.1% | -7.3% | +1.8% | -1.7% | — |
| Nov 10, 2025 | BMO | -0.12 | -0.15 | -30.4% | 6.40 | -2.3% | -7.8% | +0.0% | -1.5% | -5.7% | -1.8% | — |
| Aug 5, 2025 | BMO | -0.16 | -0.18 | -12.5% | 6.34 | +3.3% | +3.2% | -1.8% | -1.4% | +1.6% | +0.6% | — |
| May 13, 2025 | BMO | -0.27 | -0.22 | +18.5% | 4.65 | +1.1% | -7.1% | +4.6% | +1.3% | +4.1% | +3.6% | — |
| Mar 4, 2025 | BMO | -0.35 | -0.32 | +8.6% | 3.88 | +4.1% | -13.1% | -10.7% | -8.3% | +9.4% | +14.6% | — |
| Nov 12, 2024 | BMO | -0.29 | -0.23 | +20.7% | 2.92 | -3.4% | -19.9% | +1.7% | +0.4% | -1.3% | +5.1% | — |
| Aug 6, 2024 | BMO | -0.34 | -0.32 | +5.9% | 4.63 | +3.5% | -5.0% | +0.5% | -1.6% | -2.3% | +0.0% | — |
| Apr 30, 2024 | BMO | -0.37 | -0.33 | +10.8% | 5.70 | -0.4% | -0.4% | -0.2% | -0.4% | -0.5% | +1.4% | — |
| Mar 5, 2024 | BMO | -0.27 | -0.23 | +14.8% | 6.96 | +1.4% | +2.7% | -2.9% | -1.2% | -2.9% | +5.4% | — |
| Nov 7, 2023 | BMO | -0.30 | -0.22 | +26.7% | 6.16 | +0.4% | -8.7% | -11.8% | +6.0% | +7.6% | +19.1% | — |
| Aug 8, 2023 | BMO | -0.33 | -0.29 | +12.1% | 7.65 | +0.3% | -3.5% | -0.9% | -1.4% | -1.7% | -0.4% | — |
| May 9, 2023 | AMC | -0.35 | -0.39 | -11.4% | 7.58 | +2.2% | +2.1% | -2.6% | -0.8% | -2.1% | -5.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5 | Leerink Partners | Upgrade | Market Perform → Outperform | — | $6.52 | $6.45 | -1.1% | -2.8% | +3.2% | -1.8% | -1.4% | +1.6% |
| Jan 15 | Stephens & Co. | Maintains | Overweight → Overweight | — | $1.98 | $2.52 | +27.3% | +47.0% | -0.3% | +2.8% | +1.7% | -7.3% |
| Nov 13 | Leerink Partners | Downgrade | Outperform → Market Perform | — | $2.92 | $2.82 | -3.4% | -19.9% | +1.7% | +0.4% | -1.3% | +5.1% |
| Nov 13 | Stifel | Maintains | Buy → Buy | — | $2.92 | $2.82 | -3.4% | -19.9% | +1.7% | +0.4% | -1.3% | +5.1% |
| Oct 17 | Leerink Partners | Maintains | Outperform → Outperform | — | $3.53 | $3.53 | +0.0% | -2.8% | +4.7% | -2.5% | -2.0% | -0.6% |
| May 13 | Stephens & Co. | Maintains | Overweight → Overweight | — | $5.70 | $5.81 | +1.9% | +15.1% | +9.0% | +1.3% | -5.0% | -0.4% |
| Sep 25 | Stephens & Co. | Maintains | Overweight → Overweight | — | $6.04 | $6.00 | -0.7% | +0.2% | +0.8% | +6.2% | -0.9% | +3.7% |
| Feb 7 | Stephens & Co. | Maintains | Overweight → Overweight | — | $9.97 | $10.09 | +1.2% | +4.4% | -0.6% | -2.4% | +0.5% | +2.1% |
| Jan 6 | SVB Leerink | Maintains | Outperform → Outperform | — | $7.45 | $7.51 | +0.8% | -1.9% | +0.1% | +11.3% | +2.3% | -2.0% |
| Nov 15 | SVB Leerink | Maintains | Outperform → Outperform | — | $12.48 | $12.70 | +1.8% | -15.9% | +4.9% | -5.3% | -5.1% | -0.1% |
| Mar 8 | SVB Leerink | Maintains | Outperform → Outperform | — | $15.54 | $16.34 | +5.1% | +15.1% | +6.7% | -1.0% | -1.6% | -7.9% |
| May 14 | SVB Leerink | Maintains | Outperform → Outperform | — | $36.75 | $38.03 | +3.5% | +0.2% | -0.4% | +2.4% | -1.9% | +3.3% |
| Jan 12 | Stifel | Maintains | Buy → Buy | — | $56.63 | $57.42 | +1.4% | +0.9% | +0.8% | +6.6% | +1.7% | +3.9% |
| Jan 12 | SVB Leerink | Maintains | Outperform → Outperform | — | $56.63 | $57.42 | +1.4% | +0.9% | +0.8% | +6.6% | +1.7% | +3.9% |
| Jan 12 | TD Cowen | Maintains | Outperform → Outperform | — | $56.63 | $57.42 | +1.4% | +0.9% | +0.8% | +6.6% | +1.7% | +3.9% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | AWM Investment Company, Inc.10% | — | Sell | 39,782 | $8.97 | $357K | 4,887,491 | -10.09% | +2.62% |
| Jun 3, 2026 | Brown Christopher D. | — | Sell | 20,000 | $8.73 | $175K | 875,559 | -10.09% | +2.62% |
| Jun 2, 2026 | AWM Investment Company, Inc.10% | — | Sell | 2,500 | $8.95 | $22K | 4,927,273 | -10.09% | +2.62% |
| May 28, 2026 | Brown Christopher D. | — | Sell | 30,000 | $9.00 | $270K | 895,559 | +2.62% | -10.09% |
| May 28, 2026 | Griffith Joseph H. IV | Chief Financial Officer | Sell | 6,940 | $9.03 | $63K | 132,956 | +2.62% | -10.09% |
| May 11, 2026 | AWM Investment Company, Inc.10% | — | Sell | 5,000 | $8.25 | $41K | 5,116,715 | -3.18% | +2.95% |
| May 8, 2026 | Kenneweg John | SVP, Sales & Product Marketing | Sell | 18,255 | $8.11 | $148K | 57,784 | -3.53% | -3.77% |
| May 6, 2026 | Brown Christopher D. | — | Sell | 20,000 | $7.23 | $145K | 925,559 | +1.11% | -3.18% |
| May 1, 2026 | Kenneweg John | SVP, Sales & Product Marketing | Sell | 7,787 | $6.83 | $53K | 76,039 | +8.24% | -2.94% |
8-K · 2.01
!!! Very High
908 Devices Inc. -- 8-K 2.01: Acquisition Completed
May 6
8-K
908 Devices Inc. -- 8-K Filing
908 Devices reported 21% fourth quarter 2025 revenue growth and achieved positive Adjusted EBITDA, demonstrating operational improvement in its handheld chemical analysis tool business.
Mar 3
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Ark Investment Management Llc | 1,946,685 | $12M | Reduced | Mar 2026 |
| 2 | First Eagle Investment Management, Llc | 1,607,212 | $10M | Added | Mar 2026 |
| 3 | Needham Investment Management Llc | 1,240,000 | $8M | Added | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 1,119,236 | $7M | New | Mar 2026 |
| 5 | Morgan Stanley | 880,972 | $5M | Reduced | Dec 2025 |
| 6 | Tao Capital Management Lp | 568,981 | $3M | — | Mar 2026 |
| 7 | Essex Investment Management Co Llc | 491,221 | $3M | Added | Mar 2026 |
| 8 | Meros Investment Management, Lp | 361,738 | $2M | Added | Mar 2026 |
| 9 | Highmark Wealth Management Llc | 319,350 | $2M | Added | Mar 2026 |
| 10 | Prescott Group Capital Management, L.l.c. | 361,595 | $2M | Added | Dec 2025 |
| 11 | Northern Trust Corp | 241,332 | $1M | Added | Mar 2026 |
| 12 | Gm Advisory Group, Llc | 238,218 | $1M | Reduced | Mar 2026 |
| 13 | Renaissance Technologies Llc | 230,200 | $1M | Added | Mar 2026 |
| 14 | Raymond James Financial Inc | 176,520 | $1M | Reduced | Mar 2026 |
| 15 | Sei Investments Co | 164,894 | $1M | Added | Mar 2026 |
| 16 | Vanguard Portfolio Management Llc | 163,694 | $1M | New | Mar 2026 |
| 17 | Legato Capital Management Llc | 153,450 | $939K | Reduced | Mar 2026 |
| 18 | Russell Investments Group, Ltd. | 145,329 | $889K | Added | Mar 2026 |
| 19 | Citadel Advisors Llc | 144,547 | $885K | Reduced | Mar 2026 |
| 20 | Millennium Management | 142,422 | $872K | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$325.6M
Enterprise Value
$231.5M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.08x
P/B
2.17x
P/S
5.80x
P/FCF
-13.98x
EV/EBITDA
—
Shares Out
38.9M
Financials (TTM)
Revenue
$57.8M
Net Income
-$35.9M
EBITDA
-$26.6M
Free Cash Flow
-$24.6M
Op Cash Flow
-$23.7M
EPS Basic
$0.54
EPS Diluted
$-1.00
EPS Forward
$-0.41
Gross Margin
49.0%
Op Margin
-52.5%
Net Margin
-62.1%
Balance Sheet
Total Assets
$190.1M
Total Liab.
$46.4M
Total Equity
$143.7M
Cash
$113.0M
LT Debt
$0
Book Value/Sh
$3.97
Debt/Equity
0.12x
Current Ratio
4.24
Quick Ratio
3.86
Returns & Growth
ROE
13.6%
ROA
10.2%
ROIC
-22.8%
Rev Growth YoY
-5.8%
EPS Growth YoY
+125.5%
Price Returns
2W
+15.2%
1M
+23.1%
3M
+21.9%
6M
+32.4%
12M
+48.1%
Technicals
52W High
$9.34
52W Low
$5.03
50d MA
$7.62
200d MA
$6.89
RSI (14)
57.50
ATR (14)
$0.46
Beta
0.53
Avg Volume
285K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 25, 2026 8:36pm
· Source: financialmodelingprep.com